A novel nomogram predicting the early recurrence of hepatocellular carcinoma patients after R0 resection

BackgroundEarly tumor recurrence is one of the most significant poor prognostic factors for patients with HCC after R0 resection. The aim of this study is to identify risk factors of early recurrence, in addition, to develop a nomogram model predicting early recurrence of HCC patients.MethodsA total...

Full description

Bibliographic Details
Main Authors: Huanhuan Wang, Runkun Liu, Huanye Mo, Runtian Li, Jie Lian, Qingguang Liu, Shaoshan Han
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1133807/full
_version_ 1827987807227871232
author Huanhuan Wang
Runkun Liu
Huanye Mo
Runtian Li
Jie Lian
Qingguang Liu
Shaoshan Han
author_facet Huanhuan Wang
Runkun Liu
Huanye Mo
Runtian Li
Jie Lian
Qingguang Liu
Shaoshan Han
author_sort Huanhuan Wang
collection DOAJ
description BackgroundEarly tumor recurrence is one of the most significant poor prognostic factors for patients with HCC after R0 resection. The aim of this study is to identify risk factors of early recurrence, in addition, to develop a nomogram model predicting early recurrence of HCC patients.MethodsA total of 481 HCC patients after R0 resection were enrolled and divided into a training cohort (n = 337) and a validation cohort (n = 144). Risk factors for early recurrence were determined based on Cox regression analysis in the training cohort. A nomogram incorporating independent risk predictors was established and validated.ResultsEarly recurrence occurred in 37.8% of the 481 patients who underwent curative liver resection of HCC. AFP ≥ 400 ng/mL (HR: 1.662; P = 0.008), VEGF-A among 127.8 to 240.3 pg/mL (HR: 1.781, P = 0.012), VEGF-A > 240.3 pg/mL (HR: 2.552, P < 0.001), M1 subgroup of MVI (HR: 2.221, P = 0.002), M2 subgroup of MVI (HR: 3.120, P < 0.001), intratumor necrosis (HR: 1.666, P = 0.011), surgical margin among 5.0 to 10.0 mm (HR: 1.601, P = 0.043) and surgical margin < 5.0 mm (HR: 1.790, P = 0.012) were found to be independent risk factors for recurrence-free survival in the training cohort and were used for constructing the nomogram. The nomogram indicated good predictive performance with an AUC of 0.781 (95% CI: 0.729-0.832) and 0.808 (95% CI: 0.731-0.886) in the training and validation cohorts, respectively.ConclusionsElevated serum concentrations of AFP and VEGF-A, microvascular invasion, intratumor necrosis, surgical margin were independent risk factors of early intrahepatic recurrence. A reliable nomogram model which incorporated blood biomarkers and pathological variables was established and validated. The nomogram achieved desirable effectiveness in predicting early recurrence in HCC patients.
first_indexed 2024-04-09T23:52:48Z
format Article
id doaj.art-b6aa7af7a8c04258b8361af30d43c175
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-09T23:52:48Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-b6aa7af7a8c04258b8361af30d43c1752023-03-17T05:14:56ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-03-011310.3389/fonc.2023.11338071133807A novel nomogram predicting the early recurrence of hepatocellular carcinoma patients after R0 resectionHuanhuan Wang0Runkun Liu1Huanye Mo2Runtian Li3Jie Lian4Qingguang Liu5Shaoshan Han6Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of Pathology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaBackgroundEarly tumor recurrence is one of the most significant poor prognostic factors for patients with HCC after R0 resection. The aim of this study is to identify risk factors of early recurrence, in addition, to develop a nomogram model predicting early recurrence of HCC patients.MethodsA total of 481 HCC patients after R0 resection were enrolled and divided into a training cohort (n = 337) and a validation cohort (n = 144). Risk factors for early recurrence were determined based on Cox regression analysis in the training cohort. A nomogram incorporating independent risk predictors was established and validated.ResultsEarly recurrence occurred in 37.8% of the 481 patients who underwent curative liver resection of HCC. AFP ≥ 400 ng/mL (HR: 1.662; P = 0.008), VEGF-A among 127.8 to 240.3 pg/mL (HR: 1.781, P = 0.012), VEGF-A > 240.3 pg/mL (HR: 2.552, P < 0.001), M1 subgroup of MVI (HR: 2.221, P = 0.002), M2 subgroup of MVI (HR: 3.120, P < 0.001), intratumor necrosis (HR: 1.666, P = 0.011), surgical margin among 5.0 to 10.0 mm (HR: 1.601, P = 0.043) and surgical margin < 5.0 mm (HR: 1.790, P = 0.012) were found to be independent risk factors for recurrence-free survival in the training cohort and were used for constructing the nomogram. The nomogram indicated good predictive performance with an AUC of 0.781 (95% CI: 0.729-0.832) and 0.808 (95% CI: 0.731-0.886) in the training and validation cohorts, respectively.ConclusionsElevated serum concentrations of AFP and VEGF-A, microvascular invasion, intratumor necrosis, surgical margin were independent risk factors of early intrahepatic recurrence. A reliable nomogram model which incorporated blood biomarkers and pathological variables was established and validated. The nomogram achieved desirable effectiveness in predicting early recurrence in HCC patients.https://www.frontiersin.org/articles/10.3389/fonc.2023.1133807/fullhepatocellular carcinomaearly recurrencenomogram modelMVIVEGF-A
spellingShingle Huanhuan Wang
Runkun Liu
Huanye Mo
Runtian Li
Jie Lian
Qingguang Liu
Shaoshan Han
A novel nomogram predicting the early recurrence of hepatocellular carcinoma patients after R0 resection
Frontiers in Oncology
hepatocellular carcinoma
early recurrence
nomogram model
MVI
VEGF-A
title A novel nomogram predicting the early recurrence of hepatocellular carcinoma patients after R0 resection
title_full A novel nomogram predicting the early recurrence of hepatocellular carcinoma patients after R0 resection
title_fullStr A novel nomogram predicting the early recurrence of hepatocellular carcinoma patients after R0 resection
title_full_unstemmed A novel nomogram predicting the early recurrence of hepatocellular carcinoma patients after R0 resection
title_short A novel nomogram predicting the early recurrence of hepatocellular carcinoma patients after R0 resection
title_sort novel nomogram predicting the early recurrence of hepatocellular carcinoma patients after r0 resection
topic hepatocellular carcinoma
early recurrence
nomogram model
MVI
VEGF-A
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1133807/full
work_keys_str_mv AT huanhuanwang anovelnomogrampredictingtheearlyrecurrenceofhepatocellularcarcinomapatientsafterr0resection
AT runkunliu anovelnomogrampredictingtheearlyrecurrenceofhepatocellularcarcinomapatientsafterr0resection
AT huanyemo anovelnomogrampredictingtheearlyrecurrenceofhepatocellularcarcinomapatientsafterr0resection
AT runtianli anovelnomogrampredictingtheearlyrecurrenceofhepatocellularcarcinomapatientsafterr0resection
AT jielian anovelnomogrampredictingtheearlyrecurrenceofhepatocellularcarcinomapatientsafterr0resection
AT qingguangliu anovelnomogrampredictingtheearlyrecurrenceofhepatocellularcarcinomapatientsafterr0resection
AT shaoshanhan anovelnomogrampredictingtheearlyrecurrenceofhepatocellularcarcinomapatientsafterr0resection
AT huanhuanwang novelnomogrampredictingtheearlyrecurrenceofhepatocellularcarcinomapatientsafterr0resection
AT runkunliu novelnomogrampredictingtheearlyrecurrenceofhepatocellularcarcinomapatientsafterr0resection
AT huanyemo novelnomogrampredictingtheearlyrecurrenceofhepatocellularcarcinomapatientsafterr0resection
AT runtianli novelnomogrampredictingtheearlyrecurrenceofhepatocellularcarcinomapatientsafterr0resection
AT jielian novelnomogrampredictingtheearlyrecurrenceofhepatocellularcarcinomapatientsafterr0resection
AT qingguangliu novelnomogrampredictingtheearlyrecurrenceofhepatocellularcarcinomapatientsafterr0resection
AT shaoshanhan novelnomogrampredictingtheearlyrecurrenceofhepatocellularcarcinomapatientsafterr0resection